Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds ANGN.
No tracked institution reports a position in ANGN as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-06-02 | 1-for-10reverse |
No one on the platform has traded ANGN yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$IFRX Interesting new comment from Guggenheim: wonder if topic comes up Monday w KOL’s and $IFRX How does INF-904 differ from AMGN's Tavneos (oral C5aR antagonist)? Recall that Tavneos (i.e., Avacopan) $ANGN showed a late onset of improvement / separation from placebo. IFRX believes this isn't due to inherent MoA of C5aR inhibition, but rather attributed to Tavneos's PK pattern (13 weeks to reach steady-state and a steep accumulation pattern ending around week 8-10), coupled with potential underdosing.
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form 10-Q $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form 8-K $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form S-8 $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form 10-Q $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗$ANGN - Upcoming quarterly report expected on 21st of August 2023. https://www.macroaxis.com/target-price/ANGN #stocks #earnings
View on StockTwits ↗$ANGN - Next fiscal quarter end will be on 30th of June 2023. https://www.macroaxis.com/stock-analysis/ANGN/Angion-Biomedica-Corp #stocks #earnings
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form 3 $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗$ANGN https://www.channelchek.com/news-channel/what-happens-to-your-stock-holding-when-it-is-added-to-a-major-index
View on StockTwits ↗Angion Biomedica Corp. Files SEC Form 8-K $ANGN https://www.marketbeat.com/stocks/NASDAQ/ANGN/sec-filings/
View on StockTwits ↗$ANGN https://ir.elicio.com/news-releases/news-release-details/elicio-therapeutics-announces-positive-interim-data-phase-1/
View on StockTwits ↗Next reverse splits $acor $lixt $angn became eltx Haven't looked at sec filings oft offerings yet. $cjet primed like $sda
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Beat consensus in 4 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-21 | $0.57 | $-2.44 | -527.7% |
| 2023-05-10 | $-0.54 | $-0.15 | +72.2% |
| 2023-03-17 | $0.21 | $-0.11 | -152.4% |
| 2022-11-14 | $-0.36 | $-0.21 | +41.7% |
| 2022-08-15 | $-0.46 | $-0.30 | +34.8% |
| 2022-05-16 | $-0.44 | $-0.48 | -9.1% |
| 2022-03-30 | $-0.62 | $0.58 | +193.5% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ANGNAngion Biomedica Corp. | $1.00 | +0.00% | $30M | — |
| AMHVAmerican Hemp Ventures, Inc. | $0.98 | +0.00% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry